Symptomatic Relief by Bleomycin Pericardial Adhesion in a Patient With Esophageal Carcinoma and Pericardial Effusion

Abstract

Get full access to this article

View all access options for this article.

References

Maisch

Ristic

Pankuweit

Evaluation and management of pericardial effusion in patients with neoplastic disease. Prog Cardiovasc Dis. 2010;53:157-163. doi:10.1016/j.pcad.2010.06.003.

Abraham

Reddy

Gattuso

Neoplasms metastatic to the heart: review of 3314 consecutive autopsies. Am J Cardiovasc Pathol. 1990;3:195-198.

Wilkes

Fidias

Vaickus

Perez

RP.

Malignancy-related pericardial effusion. 127 cases from the Roswell Park Cancer Institute. Cancer. 1995;76:1377-1387. doi:10.1002/1097-0142(19951015)76:8<1377::aid-cncr2820760813>3.0.co;2-m.

Adler

Charron

Imazio

, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) Endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36:2921-2964. doi:10.1093/eurheartj/ehv318.

Laham

Cohen

Kuntz

Baim

Lorell

Simons

Pericardial effusion in patients with cancer: outcome with contemporary management strategies. Heart. 1996;75:67-71. doi:10.1136/hrt.75.1.67.

Kunitoh

Tamura

Shibata

, et al. A randomised trial of intrapericardial bleomycin for malignant pericardial effusion with lung cancer (JCOG9811). Br J Cancer. 2009;100:464-469. doi:10.1038/sj.bjc.6604866.

Oida

Mimatsu

Kano

, et al. Pericardiocentesis with cisplatin for malignant pericardial effusion and tamponade. World J Gastroenterol. 2010;16:740-744. doi:10.3748/wjg.v16.i6.740.

Press

Livingston

Management of malignant pericardial effusion and tamponade. JAMA. 1987;257:1088-1092. doi:10.1001/jama.257.8.1088.

Vaitkus

Herrmann

LeWinter

MM.

Treatment of malignant pericardial effusion. JAMA. 1994;272:59-64. doi:10.1001/jama.1994.03520010071035.

10.

Liu

Crump

Goss

Dancey

Shepherd

FA.

Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol. 1996;14:3141-3147. doi:10.1200/JCO.1996.14.12.3141.